Everest Medicines Ltd

01952

Company Profile

  • Business description

    Everest Medicines Ltd is a biopharmaceutical company that integrates discovery, licensing, clinical development, commercialization, and manufacturing of potentially novel or differentiated therapies and vaccines to address critical unmet medical needs initially in the Asia Pacific markets and eventually around the world. Its product pipeline includes; Nefecon (TarpeyoTM), EVER001 (previously known as XNW1011), PTX-COVID19-B, Eravacycline (Xerava), EVER206 (also known as SPR206), and others. Geographically operates in Mainland China.

  • Contact

    1168 West Nanjing Road
    16th Floor, CITIC Pacific Plaza
    Jing’an District
    Shanghai200041
    CHN

    https://www.everestmedicines.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    722

Stocks News & Analysis

stocks

This ASX miner is the cheapest in our iron ore coverage

High debt levels and low commodity prices were a concern, but agreed sell-downs and a ramp-up of key operations should help.
stocks

Apple names new CEO as Tim Cook steps aside after 15 years

John Ternus, Apple’s hardware chief, will take up the role in September.
stocks

Updating our commodity price assumptions

Our view as China’s steel production drops.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,074.3050.90-0.56%
CAC 408,235.7295.32-1.14%
DAX 4024,270.87146.93-0.60%
Dow JONES (US)49,149.38293.18-0.59%
FTSE 10010,498.09110.99-1.05%
HKSE26,148.38339.10-1.28%
NASDAQ24,259.96144.43-0.59%
Nikkei 22559,585.86236.690.40%
NZX 50 Index12,945.6013.270.10%
S&P 5007,064.0145.13-0.63%
S&P/ASX 2008,843.6053.20-0.60%
SSE Composite Index4,100.9515.870.39%

Market Movers